ERG is not normally transcriptionally controlled by androgens, but gene fusions can place ERG under transcriptional control by the androgen-regulated TMPRSS2 gene on the transition between prostatic epithelial neoplasia to prostate carcinoma. Here, ERG is linked to prostate carcinoma.